RecruitingNot ApplicableNCT07070778
Arterial Stiffness in Individuals With Breast Cancer
The Effect of Upper Extremity Aerobic Exercise Training on Arterial Stiffness in Individuals With Breast Cancer
Sponsor
Hacettepe University
Enrollment
18 participants
Start Date
Jul 8, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study was to evaluate vascular toxicity induced by anthracyclines and other anticancer drugs and to measure arterial stiffness in women with breast cancer and, in addition, to evaluate the acute and chronic arterial stiffness responses of upper extremity aerobic exercise training.
Eligibility
Sex: FEMALEMin Age: 40 YearsMax Age: 69 Years
Inclusion Criteria8
- To be between the ages of 40-69,
- Baseline left ventricular ejection fraction (LVEF) \>50%,
- Absence of coronary artery disease and haemodynamically significant valvular heart disease,
- Absence of carotid atherosclerotic plaques,
- Volunteering to participate in the research,
- At least 15 months after breast cancer surgery,
- No problems in reading and/or understanding the scales and being able to co-operate with the tests.
- Physically inactive (60 minutes of structured exercise per week \<).
Exclusion Criteria7
- Presence of active infection,
- Presence of bilateral breast cancer,
- History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
- Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- Left ventricular dysfunction and severe liver and kidney dysfunction before starting chemotherapy
- Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
- Presence of unstable hypertension or diabetes mellitus.
Interventions
OTHERUpper Extremity Aerobic Exercise Training Program
12 weeks of supervised upper limb aerobic exercise training, 3 sessions per week, 25 minutes per session.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07070778
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location